JP2021532171A - カンナビジオールの組み合わせ組成物 - Google Patents

カンナビジオールの組み合わせ組成物 Download PDF

Info

Publication number
JP2021532171A
JP2021532171A JP2021522925A JP2021522925A JP2021532171A JP 2021532171 A JP2021532171 A JP 2021532171A JP 2021522925 A JP2021522925 A JP 2021522925A JP 2021522925 A JP2021522925 A JP 2021522925A JP 2021532171 A JP2021532171 A JP 2021532171A
Authority
JP
Japan
Prior art keywords
glucosamine
cbd
composition
osteoarthritis
gln
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2021522925A
Other languages
English (en)
Japanese (ja)
Other versions
JP2021532171A5 (https=
JPWO2020009950A5 (https=
Inventor
ヴァクニン ゴーラン
バー タミー
Original Assignee
コンパニオン サイエンシズ リミテッド ライアビリティ カンパニー
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by コンパニオン サイエンシズ リミテッド ライアビリティ カンパニー filed Critical コンパニオン サイエンシズ リミテッド ライアビリティ カンパニー
Publication of JP2021532171A publication Critical patent/JP2021532171A/ja
Publication of JP2021532171A5 publication Critical patent/JP2021532171A5/ja
Publication of JPWO2020009950A5 publication Critical patent/JPWO2020009950A5/ja
Pending legal-status Critical Current

Links

Images

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/045—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
    • A61K31/047—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates having two or more hydroxy groups, e.g. sorbitol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/095—Sulfur, selenium, or tellurium compounds, e.g. thiols
    • A61K31/10—Sulfides; Sulfoxides; Sulfones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/658—Medicinal preparations containing organic active ingredients o-phenolic cannabinoids, e.g. cannabidiol, cannabigerolic acid, cannabichromene or tetrahydrocannabinol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7008—Compounds having an amino group directly attached to a carbon atom of the saccharide radical, e.g. D-galactosamine, ranimustine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A61K31/737—Sulfated polysaccharides, e.g. chondroitin sulfate, dermatan sulfate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/32—Burseraceae (Frankincense family)
    • A61K36/324—Boswellia, e.g. frankincense
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/348—Cannabaceae
    • A61K36/3482—Cannabis

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Medical Informatics (AREA)
  • Mycology (AREA)
  • Microbiology (AREA)
  • Botany (AREA)
  • Biotechnology (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Rheumatology (AREA)
  • Immunology (AREA)
  • Dermatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
JP2021522925A 2018-07-02 2019-07-01 カンナビジオールの組み合わせ組成物 Pending JP2021532171A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201862692865P 2018-07-02 2018-07-02
US62/692,865 2018-07-02
PCT/US2019/040043 WO2020009950A1 (en) 2018-07-02 2019-07-01 Cannabidiol combination compositions

Publications (3)

Publication Number Publication Date
JP2021532171A true JP2021532171A (ja) 2021-11-25
JP2021532171A5 JP2021532171A5 (https=) 2022-06-20
JPWO2020009950A5 JPWO2020009950A5 (https=) 2022-06-20

Family

ID=69060564

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2021522925A Pending JP2021532171A (ja) 2018-07-02 2019-07-01 カンナビジオールの組み合わせ組成物

Country Status (8)

Country Link
US (1) US20210275556A1 (https=)
EP (1) EP3817750A4 (https=)
JP (1) JP2021532171A (https=)
CN (1) CN112930183A (https=)
AU (1) AU2019299213A1 (https=)
BR (1) BR112020027097A2 (https=)
CA (1) CA3105082A1 (https=)
WO (1) WO2020009950A1 (https=)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BR112020017023A2 (pt) 2018-02-23 2021-03-02 Nicola Michael Spirtos terapêutica à base de cannabis e método de uso
IT201900016709A1 (it) * 2019-09-19 2021-03-19 Aqma Italia S P A Composizione antidolorifica e antinfiammatoria ad uso locale
US20210212950A1 (en) * 2020-01-15 2021-07-15 Resurgent Pharmaceuticals, Inc. Orally deliverable formulation to prevent all cause mortality and cardiovascular events
US11364255B2 (en) * 2020-07-01 2022-06-21 Karallief, Inc. Therapeutic herbal compositions for improving joint health
BR102020023664A2 (pt) * 2020-07-02 2022-01-11 Yuzu Llc Composições compreendendo canabidiol e flavononas
EP4182026A4 (en) * 2020-07-17 2024-10-02 India Globalization Capital, Inc. COMPOSITION BASED ON CANNABIDIOL (CBD) AND METHOD FOR TREATING PAIN

Citations (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2008542300A (ja) * 2005-05-24 2008-11-27 ウェルルゲン インコーポレーテッド 炎症と関連した状態を予防及び治療するための組成物及び方法
JP2009051833A (ja) * 2007-07-31 2009-03-12 Zenyaku Kogyo Kk 関節痛改善用組成物、関節痛改善剤、あるいは食品
JP2012051925A (ja) * 2004-06-08 2012-03-15 Gw Pharma Ltd 関節炎における疾患および／または症状を治療するための薬学的組成物
US20160228385A1 (en) * 2015-02-05 2016-08-11 Colorado Can Llc Purified cbd and cbda, and methods, compositions and products employing cbd or cbda
US20170266127A1 (en) * 2016-03-18 2017-09-21 Aceso Wellness LLC Cannabinoid emulsion product and process for making the same
WO2019199861A2 (en) * 2018-04-09 2019-10-17 Ellevet Sciences Hemp extract for treatment of pain in animals

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6887497B2 (en) * 2002-12-19 2005-05-03 Vitacost.Com, Inc. Composition for the treatment and prevention of osteoarthritis, rheumatoid arthritis and improved joint function
PL2444081T3 (pl) * 2010-10-19 2015-09-30 Parenteral A S Kompozycja do leczenia chorób zapalnych, zawierająca kwas bosweliowy i kannabidiol
SG10201402819WA (en) * 2014-06-02 2016-01-28 Beauty Nation Pte Ltd Composition for prevention and treatment of joint pain and the method of preparation thereof
US9486476B2 (en) * 2014-08-05 2016-11-08 Natures Products, Inc Fast acting joint relief formulations
US10398776B1 (en) * 2014-11-03 2019-09-03 Essential Green Goodness LLC Phonophoretic cannabidiol composition and transdermal delivery system
CA3025208A1 (en) * 2016-05-24 2017-11-30 Bol Pharma Ltd. Compositions comprising cannabidiol and hyaluronic acid for treating inflammatory joint diseases
US10945967B2 (en) * 2017-05-30 2021-03-16 Jae Wang. Song Formulations of a transdermal patch for pain management
US20190000794A1 (en) * 2017-12-27 2019-01-03 Daniel S. Tanaka Transmucosal cannabinoid formulation including a chitosan excipeint
CN110575432B (zh) * 2018-06-08 2021-10-12 汉义生物科技（北京）有限公司 一种含有大麻二酚的组合物及其在动物用品中的应用
WO2020021545A1 (en) * 2018-07-25 2020-01-30 Bol Pharma Ltd. Cannabidiol and glucosamine for treating inflammatory joint diseases

Patent Citations (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2012051925A (ja) * 2004-06-08 2012-03-15 Gw Pharma Ltd 関節炎における疾患および／または症状を治療するための薬学的組成物
JP2008542300A (ja) * 2005-05-24 2008-11-27 ウェルルゲン インコーポレーテッド 炎症と関連した状態を予防及び治療するための組成物及び方法
JP2009051833A (ja) * 2007-07-31 2009-03-12 Zenyaku Kogyo Kk 関節痛改善用組成物、関節痛改善剤、あるいは食品
US20160228385A1 (en) * 2015-02-05 2016-08-11 Colorado Can Llc Purified cbd and cbda, and methods, compositions and products employing cbd or cbda
US20170266127A1 (en) * 2016-03-18 2017-09-21 Aceso Wellness LLC Cannabinoid emulsion product and process for making the same
WO2019199861A2 (en) * 2018-04-09 2019-10-17 Ellevet Sciences Hemp extract for treatment of pain in animals

Also Published As

Publication number Publication date
EP3817750A4 (en) 2022-05-04
WO2020009950A1 (en) 2020-01-09
CN112930183A (zh) 2021-06-08
AU2019299213A1 (en) 2021-02-11
BR112020027097A2 (pt) 2021-03-30
CA3105082A1 (en) 2020-01-09
US20210275556A1 (en) 2021-09-09
EP3817750A1 (en) 2021-05-12

Similar Documents

Publication Publication Date Title
JP2021532171A (ja) カンナビジオールの組み合わせ組成物
EP2037902B1 (en) Cannabinoids for use in the treatment of neuropathic pain
ES2935605T3 (es) Combinaciones de cannabinoides y N-aciletanolaminas
JP7322094B2 (ja) 疼痛、掻痒症および炎症のためのストロンチウムをベースとする組成物および製剤
WO2016141219A1 (en) Strontium based compositions and formulations for pain, pruritus, and inflammation
KR102350519B1 (ko) 말초성 염증 및 통증을 감소시키는데 유용한 울금 및 에키네시아 안구스티폴리아의 추출물을 함유하는 조성물
RU2701720C1 (ru) Комбинации пальмитоилэтаноламида для лечения хронической боли
WO2019241702A1 (en) Anti-inflammatory formulations and uses thereof including a combination of palmitoylethanolamide and plant-based polyphenols
CA3219671A1 (en) Quercetin-containing compositions for use in treating amyotrophic lateral sclerosis
CN100522983C (zh) 梓醇及其同系物的医药用途
AU2016218950B2 (en) Analgesic formulation
JPWO2017111069A1 (ja) 止痒剤
US12220396B2 (en) Formulation for pain management
RU2307651C2 (ru) Каппа-опиатные агонисты для лечения заболеваний мочевого пузыря
KR20250004041A (ko) 삼차 신경통 치료 및 그와 관련된 통증 감소에 사용하기 위한 트리메프라진
AU2014270341A1 (en) Treatment or prevention of non-inflammatory neuronal damage from brain trauma and strokes using Menthol, Linalool and/or Icilin
MXPA04004380A (es) Tratamiento y prevencion de parestesia que comprende co-terapia con derivados anticonvulsivos y potasio.

Legal Events

Date Code Title Description
A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20220609

A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20220609

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20230530

A977 Report on retrieval

Free format text: JAPANESE INTERMEDIATE CODE: A971007

Effective date: 20230531

A02 Decision of refusal

Free format text: JAPANESE INTERMEDIATE CODE: A02

Effective date: 20231226